Covidien Keeps Medical Supplies Unit On Watch List After Sale Of Diaper Biz
This article was originally published in The Gray Sheet
Executive Summary
Diversified med-tech firm Covidien will continue evaluating potential divestitures following the sale of its diaper-making retail unit, according to the company
You may also be interested in...
Covidien Reports No Procedure Slowdown, Boosts Fiscal 2008 Guidance
Covidien's second quarter results, which beat analyst expectations, revealed no sign of a slowdown in U.S. surgical procedure volume, a trend that had been hinted at last month by Johnson & Johnson
Covidien Reports No Procedure Slowdown, Boosts Fiscal 2008 Guidance
Covidien's second quarter results, which beat analyst expectations, revealed no sign of a slowdown in U.S. surgical procedure volume, a trend that had been hinted at last month by Johnson & Johnson
Covidien Enters Biologic Tissue Implant Market Via $80 Mil. TSL Acquisition
Covidien gains the Permacol biologic tissue repair implant for hernias and other applications through its $80 million purchase of Tissue Science Laboratories, announced March 12